Skip to main content
Fig. 5 | Cancer & Metabolism

Fig. 5

From: Identification of predictive biomarkers for endometrial cancer diagnosis and treatment response monitoring using plasma metabolome profiling

Fig. 5

Metabolites associated with relapse in patients with EMC. The Kaplan–Meier survival analysis divided the patients into two groups according to the median metabolite concentration and compared the days of recurrence using the log-rank test. The black line shows group 1, the red line shows group 2, the vertical axis shows the probability of recurrence, and the horizontal axis shows days of elapse

Back to article page

Cancer & Metabolism

ISSN: 2049-3002